The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  European Journal of Pharmacology

• Publication date

  1990-08-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0014-2999(90)90668-VPMID 2120077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quipazine Increases Renin Release by a Peripheral Hemodynamic Mechanism

  1990cited by this paper
• Vascular pharmacology of 5-hydroxytryptamine in humans

  1990cited by this paper
• 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge.

  1988cited by this paper
• Quipazine reduces food intake in the rat by activation of 5‐HT2‐receptors

  1988cited by this paper
• Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.

  1987cited by this paper
• Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.

  1987cited by this paper
• Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.

  1987cited by this paper
• Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists.

  1987cited by this paper
• Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve

  1987cited by this paper
• Pharmacological evidence that the sympathetic nervous system mediates the increase in secretion of renin produced by p-chloroamphetamine.

  1984cited by this paper
• Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5‐hydroxytiyptamine

  1984cited by this paper
• Evidence that serotonergic neurons in the dorsal raphe nucleus exert a stimulatory effect on the secretion of renin but not of corticosterone.

  1982cited by this paper
• Mechanism of the Hypotensive Effect of Ketanserin

  1982cited by this paper
• Evidence that the mediobasal hypothalamus is involved in serotonergic stimulation of renin secretion.

  1982cited by this paper
• Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.

  1981cited by this paper
• Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

  1981cited by this paper
• The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.

  1978cited by this paper
• Quipazine-induced head-twitch in mice.

  1977cited by this paper
• The effects of quipazine on serotonin metabolism in rat brain.

  1976cited by this paper
• The effects of quipazine on 5-HT metabolism in the rat brain

  1976cited by this paper
• Antinociceptive action of quipazine: Relation to central serotonergic receptor stimulation

  1976cited by this paper
• Effect of quipazine on rat plasma prolactin levels.

  1976cited by this paper
• The effect of a serotonin uptake inhibitor (Lilly 110140) on the sercretion of prolactin in the rat.

  1975cited by this paper
• Serotonin-like actions of quipazine on the central nervous system.

  1973cited by this paper
• Some behavioral effects induced by quipazine administration in the cat.

  1970cited by this paper
• Similarities between the pharmacological actions of quipazine and serotonin.

  1969cited by this paper
• ON THE PHARMACOLOGY OF 2-(1-PIPERAZINYL)QUINOLINE

  1966cited by this paper

• Cardiovascular Effects of a Novel Synthetic Analogue of Naturally Occurring Piperamides

  2010cites this paper
• 5HT2 and 5HT3 receptors' contribution to modeling of post-serotonin respiratory pattern in cats.

  2004cites this paper
• Evidence for a role for central 5‐HT2B as well as 5‐HT2A receptors in cardiovascular regulation in anaesthetized rats

  1999cites this paper
• The central sympatho-inhibitory effect of 5,6-dihydroxy-2-dimethylaminotetralin (M7) is mediated by alpha 2-adrenoceptors.

  1997cites this paper
• A comparative study of the reversal by different α2‐adrenoceptor antagonists of the central sympatho‐inhibitory effect of clonidine

  1996cites this paper
• The interaction of trichloroethanol with murine recombinant 5‐HT3 receptors

  1995cites this paper
• Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats.

  1993cites this paper
• mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.

  1992cites this paper
• Central administration of 5‐HT activates 5‐HT1A receptors to cause sympathoexcitation and 5‐HT2/5‐HT1C receptors to release vasopressin in anaesthetized rats

  1992cites this paper
• Central serotonergic stimulation of renin secretion

  1992cites this paper
• Chapter 11. Serotonin Modulators and Cardiovascular/Gastrointestinal Diseases

  1991cites this paper
• 5-Hydroxytryptamine-induced vasodilatation in the isolated perfused rat kidney: are endothelial 5-HT1A receptors involved?

  1991cites this paper
• Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area.

  1991cites this paper
• Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation.

  1991cites this paper
• Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.

  1991cites this paper